Our results showed that compared with the AA group, MTX and high-dose QED groups had a significantly higher levels of TGF-β in rats with arthritis (P < 0.05, P < 0.01), while moderate- and low-dose QED had no such effect (Fig. 7). Here, TGFB1 is linked to arthritic joint disease.